Literature DB >> 11553931

Mitochondrial defects in neurodegenerative disease.

D C Wallace1.   

Abstract

Over the past 12 years, a wide variety of neurodegenerative diseases has been linked to mutations in mitochondrial genes located in either the mitochondrial DNA (mtDNA) or the nuclear DNA (nDNA). These disorders encompass an array of unorthodox inheritance patterns and a plethora of symptoms ranging from lethal neonatal multi-symptom disorders to later onset myopathies, cardiomyopathies, movement disorders, and dementias. The bases for the genetic and phenotypic variability of mitochondrial diseases lie in the multiplicity of the mitochondria genes dispersed across the human genome and the variety of cellular pathways and functions in which the mitochondria play a central role. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553931     DOI: 10.1002/mrdd.1023

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  12 in total

Review 1.  Mitochondrial biogenesis and turnover.

Authors:  Francisca Diaz; Carlos T Moraes
Journal:  Cell Calcium       Date:  2008-04-18       Impact factor: 6.817

2.  Quantitative analysis of axonal transport by using compartmentalized and surface micropatterned culture of neurons.

Authors:  Hyung Joon Kim; Jeong Won Park; Jae Hwan Byun; Wayne W Poon; Carl W Cotman; Charless C Fowlkes; Noo Li Jeon
Journal:  ACS Chem Neurosci       Date:  2012-06-20       Impact factor: 4.418

3.  Riboflavin and migraine: the bridge over troubled mitochondria.

Authors:  Bruno Colombo; Lorenzo Saraceno; Giancarlo Comi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

4.  Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study.

Authors:  Beatrice A Golomb; Edwin K Kwon; Sabrina Koperski; Marcella A Evans
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Genetic ablation of calcium-independent phospholipase A2gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype.

Authors:  David J Mancuso; Harold F Sims; Xianlin Han; Christopher M Jenkins; Shao Ping Guan; Kui Yang; Sung Ho Moon; Terri Pietka; Nada A Abumrad; Paul H Schlesinger; Richard W Gross
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

Review 6.  Mitochondrial DNA damage and repair in neurodegenerative disorders.

Authors:  Jenq-Lin Yang; Lior Weissman; Vilhelm A Bohr; Mark P Mattson
Journal:  DNA Repair (Amst)       Date:  2008-05-07

7.  Mitochondrial DNA haplogroups do not play a role in the variable phenotypic presentation of the A3243G mutation.

Authors:  Antonio Torroni; Yolanda Campos; Chiara Rengo; Daniele Sellitto; Alessandro Achilli; Chiara Magri; Ornella Semino; Alberto García; Pilar Jara; Joaquín Arenas; Rosaria Scozzari
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

8.  mtDNA nt13708A variant increases the risk of multiple sclerosis.

Authors:  Xinhua Yu; Dirk Koczan; Anna-Maija Sulonen; Denis A Akkad; Antje Kroner; Manuel Comabella; Gianna Costa; Daniela Corongiu; Robert Goertsches; Montserrat Camina-Tato; Hans-Juergen Thiesen; Harald I Nyland; Sverre J Mørk; Xavier Montalban; Peter Rieckmann; Maria G Marrosu; Kjell-Morten Myhr; Joerg T Epplen; Janna Saarela; Saleh M Ibrahim
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

9.  Arrhythmia as a cardiac manifestation in MELAS syndrome.

Authors:  Tamara Thomas; William J Craigen; Ryan Moore; Richard Czosek; John L Jefferies
Journal:  Mol Genet Metab Rep       Date:  2015-06-03

Review 10.  Mitochondrial diseases caused by mtDNA mutations: a mini-review.

Authors:  Anastasia I Ryzhkova; Margarita A Sazonova; Vasily V Sinyov; Elena V Galitsyna; Mariya M Chicheva; Alexandra A Melnichenko; Andrey V Grechko; Anton Yu Postnov; Alexander N Orekhov; Tatiana P Shkurat
Journal:  Ther Clin Risk Manag       Date:  2018-10-09       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.